208 related articles for article (PubMed ID: 27792870)
1. Phenome-Wide Association Study of Autoantibodies to Citrullinated and Noncitrullinated Epitopes in Rheumatoid Arthritis.
Liao KP; Sparks JA; Hejblum BP; Kuo IH; Cui J; Lahey LJ; Cagan A; Gainer VS; Liu W; Cai TT; Sokolove J; Cai T
Arthritis Rheumatol; 2017 Apr; 69(4):742-749. PubMed ID: 27792870
[TBL] [Abstract][Full Text] [Related]
2. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls.
Liao KP; Kurreeman F; Li G; Duclos G; Murphy S; Guzman R; Cai T; Gupta N; Gainer V; Schur P; Cui J; Denny JC; Szolovits P; Churchill S; Kohane I; Karlson EW; Plenge RM
Arthritis Rheum; 2013 Mar; 65(3):571-81. PubMed ID: 23233247
[TBL] [Abstract][Full Text] [Related]
3. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
4. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
5. Phenome-Wide Association Study of Rheumatoid Arthritis Subgroups Identifies Association Between Seronegative Disease and Fibromyalgia.
Doss J; Mo H; Carroll RJ; Crofford LJ; Denny JC
Arthritis Rheumatol; 2017 Feb; 69(2):291-300. PubMed ID: 27589350
[TBL] [Abstract][Full Text] [Related]
6. Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to Eosinophilic Esophagitis.
Namjou B; Marsolo K; Caroll RJ; Denny JC; Ritchie MD; Verma SS; Lingren T; Porollo A; Cobb BL; Perry C; Kottyan LC; Rothenberg ME; Thompson SD; Holm IA; Kohane IS; Harley JB
Front Genet; 2014; 5():401. PubMed ID: 25477900
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
8. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
9. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.
Raslan HM; Attia HR; Salama I; Ibrahim MH; Hassan EM; El Hussieny MS; El Menyawi MM; Amr KS
Rheumatol Int; 2016 Aug; 36(8):1167-75. PubMed ID: 27324632
[TBL] [Abstract][Full Text] [Related]
10. Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis.
Svärd A; Skogh T; Alfredsson L; Ilar A; Klareskog L; Bengtsson C; Kastbom A
Arthritis Rheumatol; 2015 May; 67(8):2032-7. PubMed ID: 25916813
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function mutations in the filaggrin gene: no contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis.
Hüffmeier U; Böiers U; Lascorz J; Reis A; Burkhardt H
Ann Rheum Dis; 2008 Jan; 67(1):131-3. PubMed ID: 17704064
[TBL] [Abstract][Full Text] [Related]
12. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
[TBL] [Abstract][Full Text] [Related]
13. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
15. INTEGRATING CLINICAL LABORATORY MEASURES AND ICD-9 CODE DIAGNOSES IN PHENOME-WIDE ASSOCIATION STUDIES.
Verma A; Leader JB; Verma SS; Frase A; Wallace J; Dudek S; Lavage DR; Van Hout CV; Dewey FE; Penn J; Lopez A; Overton JD; Carey DJ; Ledbetter DH; Kirchner HL; Ritchie MD; Pendergrass SA
Pac Symp Biocomput; 2016; 21():168-79. PubMed ID: 26776183
[TBL] [Abstract][Full Text] [Related]
16. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
17. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
Gyetvai A; Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Teodorescu M; Sipka S; Szegedi G; Lakos G
Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
[TBL] [Abstract][Full Text] [Related]
18. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
19. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.
El-Gabalawy HS; Robinson DB; Smolik I; Hart D; Elias B; Wong K; Peschken CA; Hitchon CA; Li X; Bernstein CN; Newkirk MM; Fritzler MJ
Arthritis Rheum; 2012 Jun; 64(6):1720-9. PubMed ID: 22354869
[TBL] [Abstract][Full Text] [Related]
20. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
